Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

To assess the effects of bacillus Calmette-Guérin (BCG) intravesical therapy compared to mitomycin C (MMC) intravesical therapy for treating Ta and T1 bladder cancer in adults.

This is a protocol.

Share/Save
Health topics: